Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)

CUSIP: 45258J102

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
202,731,676
Total 13F shares
28,564,750
Share change
+15,935,424
Total reported value
$695,567,285
Price per share
$24.35
Number of holders
87
Value change
+$388,041,409
Number of buys
75
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 45258J102?
CUSIP 45258J102 identifies IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q2 2020

As of 30 Jun 2020, Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by 87 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,564,750 shares. The largest 10 holders included RTW INVESTMENTS, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Inc., Polar Capital LLP, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, PICTET ASSET MANAGEMENT LTD, BVF INC/IL, DRIEHAUS CAPITAL MANAGEMENT LLC, and Camber Capital Management LP. This page lists 87 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.